Elucidating disparities in sunscreen coverage among state Medicaid preferred drug lists
- 30 September 2024
- journal article
- research article
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (1) , 88-90
Abstract
Regular application of over‐the‐counter (OTC) sunscreen is considered the foundation of skin cancer prevention, yet OTC sunscreen is not eligible for reimbursement in almost all state Medicaid benefit plans. On review of 111 Medicaid preferred drug lists (PDLs) across 50 states and the District of Columbia (DC), only five plans were identified that incorporate coverage of sunscreen. Thus, many recipients of Medicaid, the majority of whom are individuals and families of lower socioeconomic status, may encounter financial difficulty and thus forego utilizing sun protective measures due to financial constraints. Here, we compare current Medicaid coverage of OTC sunscreen and discuss calculated and theoretical annual costs of this skin cancer prevention method.Keywords
Funding Information
- Pediatric Dermatology Research Alliance
This publication has 7 references indexed in Scilit:
- State medicaid coverage of over‐the‐counter moisturizers: A cost‐effective management strategy for atopic dermatitis?Pediatric Dermatology, 2022
- Disparities in availability of skin therapies found in public assistance formulariesJournal of the American Academy of Dermatology, 2022
- Sunscreen Use and Melanoma Risk Among Young Australian AdultsJAMA Dermatology, 2018
- Patterns of sunscreen use on the face and other exposed skin among US adultsJournal of the American Academy of Dermatology, 2015
- Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-UpJournal of Clinical Oncology, 2011
- Regular Sunscreen Use Is a Cost-Effective Approach to Skin Cancer Prevention in Subtropical SettingsJournal of Investigative Dermatology, 2009
- Risk Reduction for Nonmelanoma Skin Cancer With Childhood Sunscreen UseArchives of Dermatology, 1986